Industry
Roche's Persistence Plus 19% Premium Over Initial Offer Wins Ventana
In an acquisition process that started June 2007, Roche, after feeling the sting of rejection five times, made a sixth offer Ventana did not refuse and the Swiss biotech giant carried off the prize for a fortune. More...30 Nov -0001
In Other News
Kinase Assay Offers New Approach to Analyzing Oncology Targets
TSH Receptor Antibody Assay Developed for Grave's Disease
Rapid Flow-Through Testing Technology Expanded for HIV Diagnosis
Aerocrine's Portable Asthma Monitor Launched in France, China
Biotechnology Firm Enters Cardiology Testing Field
China Medical Technologies Acquires Beijing Bio-Ekon Biotechnology
Roche's Infectious Disease Portfolio To Include HCV Immunodiagnostics
TB Antigen in Urine Helps Diagnose Current Mycobacterium Infection
Bio-Rad Completes Purchase of Diamed
Inverness Medical Innovations to Acquire Alere Medical
Thermo Fisher Scientific Acquires Micro-Volume UV-Vis Instrumentation
New Biotech Company Will Focus on POC Diagnostics
Acquisition of Atria Gives Celera Direct Access to Tissue Typing
IVD Cancer Diagnostic Products to be Based on Microarrays
Diagnocure Acquires Diagnostic Tests for Breast and Colon Cancer
Molecular Diagnostics Company Signs Worldwide License for Key Technologies
Integrated Solution for Diabetes Testing Is Efficient
Warnex Receives License To Market Leukemia Service in Canada
Liquid-Handling Workstations Automate Multi-Gene Expression Assay Development
Capping Laboratory Diagnostics Strategy, Siemens to Acquire Dade Behring for $7 Billion
Collaboration to Develop Molecular Tests for Healthcare-Associated Infections
New Instrument Promises Increased High-Throughput Screening
Immunicon and Diagnostic Hybrids Sign Distribution Agreement
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.